Hot Topics

• NYSDOH: Announcing PrEP Aware Week: October 19-25, 2025
• NYSDOH: Testing Urged for Syphilis Following Third Presumed Syphilis-Related Infant Death Outside of NYC this Year
• NYSDOH: STI Dashboard NY: Tracking Mpox and Syphilis in New York State
• CEI: Complete the 2025 Annual Survey
• CEI: STIs & Pregnancy: A New Online Learning Pathway
• CEI: New Online Accredited Courses & Learning Modules

See all Hot Topics

Save the Date: PrEP Aware Week 2025

Learn more at prepforsex.org

Don't Miss

Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults

• Purpose of This Guideline
• Efficacy of CAB/RPV LA
• Benefits, Potential Risks, and Limitations of CAB/RPV LA
• Initiation, Maintenance, and Discontinuation of CAB/RPV LA as ART
• Laboratory Testing and Patient Follow-Up
• Implementing CAB/RPV LA in Clinical Practice
• All Recommendations
• Printable PDF
• Pocket Guide
• Slide Set

Updated: Second-Line ART After Treatment Failure or for Regimen Simplification

• Purpose of This Guideline
• Identifying and Managing Virologic Failure
• ART Changes to Address Drug Resistance
• ART Changes for Adverse Effects, Drug-Drug Interactions, or Pregnancy
• ART Changes for Regimen Simplification
• Resumption of ART After a Treatment Interruption
• All Recommendations
• Printable PDF
• Pocket Guide
• Slide Set

Updated: Prevention and Treatment of Mpox

• Purpose of This Guideline
• Mpox Prevention
• Mpox Presentation and Diagnosis
• Mpox Treatment
• All Recommendations
• Printable PDF
• Pocket Guide
• Slide Set

Case 4. Under Pressure: Cryptococcus, ART Initiation, and the Threat of IRIS: After brief mention of an HIV vaccine, the hosts turn to the challenges of treating cryptococcal meningitis in a 46-year-old woman with profound immune suppression after being off ART for 6-12 months. Emphasizing the high potential for morbidity and mortality, Chris and Eileen focus on the complexities of cryptococcal meningitis medical management, including the role of immune constitution, timing of ART initiation, and the risk of IRIS. Listen as they work through the treatment requirements and clinical decisions involved in this complicated case. Listen Now

Case 5. The Heart of the Matter Cardiovascular Disease Risk in HIV: COVID-19 vaccine policy, proviral DNA testing, then the case of a woman with 10+ years viral suppression, CKD, and CVD, identified as a statin candidate after a significant cardiac event. With no family history of CVD, her risks included exposure to older ARVs and smoking 1 to 3 cigarettes/day. Listen as Drs. Scully and Hoffmann delve into non-infectious comorbidities associated with HIV, risk factors, and adjusted CVD risk calculation for women and African Americans. Listen Now

Coming Soon

Case 6. Is More Really More? Optimizing Options for a Healthy Patient: Healthy 48-year-old man with HIV for 15 years, stable viral suppression, looking to optimize health—diet, exercise, immune-boosting supplements, safest HIV and HTN meds. Listen as Chris and Eileen discuss their approach to giving patients the good news about their health, health maintenance, supplement use, and whether to stay the course or switch ART regimens in patients who are doing well. Listen September 16

Case 7. Newer Kids on the Block: Use of Novel ARVs for Multidrug Resistance: How to formulate an effective ART regimen acceptable to a 56-year-old man, with unsuppressed HIV, 20+ year ART history, extensive drug resistance, and adherence challenges? Listen as Eileen and Chris interpret resistance testing results, discuss barriers to treatment and adherence for this patient, and evaluate the possibility of using one of the novel agents—fostemsavir, ibalizumab, and lenacapavir. What would you do? Listen October 7

Evolving Landscape of Geriatric HIV Care: The demographics of HIV care are rapidly changing, and with them, the clinical needs of patients aging with HIV. In this episode, host Dr. Tony Urbina, Medical Director for CEI's HIV Primary Care and Prevention Center of Excellence, sits down with geriatrician Dr. Angela Condo to explore the unique intersection of geriatric medicine and HIV care. Listen Now

CEI:

• 9/17: This Month in HIV: Comprehensive Primary Care for People Living with HIV

See all

General:

• 9/12: NAHEWD: Harm Reduction Approaches to Substance Use Disorder Treatment for Non-Abstinent Patients
• 9/15: Addiction Medicine Advocacy Conference 2025
• 9/17: NYSDOH AI: Sex Worker Health Training Part 1
• 9/22: NYSDOH AI: Sex Worker Health Training Part 2
• 9/26: USPATH 2025 Scientific Symposium
• 9/29: NYSDOH AI: Congenital Syphilis Elimination Framework Discussion Forum: Private Sector
• 9/30: NYSDOH AI: PrEP Aware Week 2025: Meet the Ambassadors & Learn about the Social Media Toolkit
• 10/6: National Sexual Health Conference
• 10/19: NYSDOH AI: 2025 PrEP Aware Week
• 10/19: IDWeek 2025
• 10/29: NYSDOH AI: Congenital Syphilis Elimination Framework Discussion Forum: Clinical & Non-Clinical Providers
• 11/1: National Conference on Correctional Health Care
• 11/6: ANAC2025
• 11/18: The Union World Conference on Lung Health 2025
• 12/6: ISAM Americas Summit – 2025 Annual Conference
• 12/14: 2025 Ryan White HIV/AIDS Program Clinical Conference
• 2/22/2026: CROI 2026
• 4/23/2026: ASAM 57th Annual Conference: Innovations in Addiction Medicine and Science
• 4/30/2026: ACTHIV 2026
• 7/25/2026: AIDS 2026, the 26th International AIDS Conference
• 11/8/2026: WPATH 2026

See all